Theravance Biopharma Announces Presentations at Upcoming Investor Conferences

DUBLIN, Feb. 18, 2020 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will webcast Management presentations: SVB Leerink 9th Annual Global…

About the Author

has written 41558 stories on this site.

Copyright © 2010 Business and Corporate News.